Search
Displaying 301–310 of 470 results for “fut credit Visitez le site Buyfc26coins.com Support incomparable pour mes FC 26 coins.K5QU”
-
Fundraiser Success Stories
Lindsey Blankenship, president of the Foundation Fighting Blindness Colorado Chapter, has created a one-of-a-kind Raising Our Sights Event. Wine for a Cure aims to spread awareness and fundraise on behalf of the Foundation Fighting Blindness with two signature wines from the Oregon Winery, Stoller Family Estates. The featured wines are a Chardonnay named “Variant” and a Pinot Noir named “Pigmentosa.”
-
Research News
Dr. Tucker is leading the development of GMP facilities for manufacturing clinical grade retinal therapies
-
Foundation News
The May 11th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
Geographic Atrophy: The Advanced Form of Dry AMD
Research NewsGeographic atrophy causes significant central vision loss and remains an unmet medical need.
-
Beacon Stories
Sean was diagnosed with dry age-related macular degeneration (AMD) in his 40s. Now Sean is using his AMD as an opportunity to educate others about the spectrum of blinding diseases while fundraising for the Foundation Fighting Blindness.
-
Blind Paralympian Reaching New Heights
Beacon StoriesIsaac Jean-Paul was diagnosed with X-linked juvenile retinoschisis (XLRS) at the age of two. Isaac was always set on being a professional athlete, and now he’s a Paralympian, winning bronze in the long jump in the 2020 Games and breaking the high jump world record three times.
-
Foundation Fighting Blindness to Host their Spring VisionWalks
Foundation NewsThese VisionWalk events taking place this spring will raise awareness and fund research finding treatments and cures for blinding retinal diseases.
-
Fearless Sister Duo Finding Hope
Beacon StoriesApril LuFriu and Melissa Escobio are sisters and best friends who do just about everything together, including having retinitis pigmentosa (RP).
-
Opus Genetics Acquires Rights to Gene Therapies for BEST1 and RP (RHO)
Research NewsThe company plans to seek clinical trial authorization for the BEST1 gene therapy during the second half of 2023
-
Editas Reports Results for 14 Participants in its Phase 1/2 CRISPR/Cas9 Clinical Trial for LCA10
Research NewsThe company is seeking a partner to move the LCA10 program forward
